Showing 1 - 3 results of 3 for search 'DART Virology Group', query time: 0.03s Refine Results
  1. 1
    Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa.

    Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa. by DART Virology Group and Trial Team

    Published 2006
    Journal article
  2. 2
    Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.

    Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. by Katherine A Sutherland, Chris M Parry, Adele McCormick, Anne Kapaata, Fred Lyagoba, Pontiano Kaleebu, Charles F Gilks, Ruth Goodall, Moira Spyer, Cissy Kityo, Deenan Pillay, Ravindra K Gupta, DART Virology Group

    Published 2016-01-01
    Get full text
    Article
  3. 3
    Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.

    Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. by Katherine A Sutherland, Chris M Parry, Adele McCormick, Anne Kapaata, Fred Lyagoba, Pontiano Kaleebu, Charles F Gilks, Ruth Goodall, Moira Spyer, Cissy Kityo, Deenan Pillay, Ravindra K Gupta, DART Virology Group

    Published 2015-01-01
    Get full text
    Article

Search Tools: